Sun Yongan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Parkinson's disease is a movement disorder that currently affects about 27 million people worldwide. The average age of Parkinson's disease in China is 60 years old, and the number of patients has exceeded 300 million. In addition to drugs and surgical treatment, researchers are also exploring some new treatments for Parkinson's Disease, such as immunotherapy, stem cell therapy, nanomaterial preparation therapy, etc. There is a "honeymoon phase" in drug treatment, and dopamine neurons in the substantia nigra region of the brain degenerate significantly in Parkinson's patients. ....

United States , Tang Fang , Zhang Liyan , Sun Yongan , Swiss Federal Institute Of Technology , Xiangya Hospital Of Central South University , Technology Daily , School Of Pharmacy Nankai University , Chinese Academy Of Sciences , World Parkinson , Peking University First Hospital , Beijing Friendship Hospital , Capital Medical University , Xiangya Hospital , Central South University , Primate Translational Medicine , Kunming University , Professor Xue , Nankai University , Chinese Academy , Swiss Federal Institute , Dopamine Neurons , P Sheets ,